JAMA (Journal of the American Medical Association)
Open in Telegram
All the latest articles published on JAMA before going in to print Discussion Group https://t.me/Medical_Professionals_Forum Contact us https://t.me/Contact_Updates_in_Medicine_Bot
Show more📈 Analytical overview of Telegram channel JAMA (Journal of the American Medical Association)
Channel JAMA (Journal of the American Medical Association) (@jamaupdates) in the English language segment is an active participant. Currently, the community unites 16 441 subscribers, ranking 1 463 in the Medicine category and 2 256 in the USA region.
📊 Audience metrics and dynamics
Since its creation on невідомо, the project has demonstrated rapid growth, gathering an audience of 16 441 subscribers.
According to the latest data from 21 September, 2026, the channel demonstrates stable activity. Although there has been a change in the number of participants by 298 over the last 30 days and by 8 over the last 24 hours, overall reach remains high.
- Verification status: Not verified
- Engagement rate (ER): The average audience engagement rate is 4.08%. Within the first 24 hours after publication, content typically collects 1.99% reactions from the total number of subscribers.
- Post reach: On average, each post receives 671 views. Within the first day, a publication typically gains 327 views.
- Reactions and interaction: The audience actively supports content: the average number of reactions per post is 1.
- Thematic interests: Content is focused on key topics such as patient, disease, treatment, drug, guideline.
📝 Description and content policy
The author describes the resource as a platform for expressing subjective opinions:
“All the latest articles published on JAMA before going in to print
Discussion Group
https://t.me/Medical_Professionals_Forum
Contact us
https://t.me/Contact_Updates_in_Medicine_Bot”
Thanks to the high frequency of updates (latest data received on 22 September, 2026), the channel maintains relevance and a high level of publication reach. Analytics show that the audience actively interacts with content, making it an important point of influence in the Medicine category.
16 441
Subscribers
+824 hours
+867 days
+29830 days
Data loading in progress...
Similar Channels
Tags Cloud
Incoming and Outgoing Mentions
---
---
---
---
---
---
Attracting Subscribers
September '26
September '26
+226
in 0 channels
August '26
+361
in 0 channels
Get PRO
July '26
+440
in 0 channels
Get PRO
June '26
+422
in 0 channels
Get PRO
May '26
+584
in 0 channels
Get PRO
April '26
+437
in 0 channels
Get PRO
March '26
+217
in 0 channels
Get PRO
February '26
+247
in 0 channels
Get PRO
January '26
+321
in 0 channels
Get PRO
December '25
+277
in 0 channels
Get PRO
November '25
+366
in 2 channels
Get PRO
October '25
+164
in 0 channels
Get PRO
September '25
+12
in 0 channels
Get PRO
August '25
+29
in 0 channels
Get PRO
July '25
+30
in 0 channels
Get PRO
June '25
+17
in 0 channels
Get PRO
May '25
+9
in 0 channels
Get PRO
April '25
+5
in 0 channels
Get PRO
March '25
+17
in 0 channels
Get PRO
February '25
+12
in 0 channels
Get PRO
January '25
+18
in 1 channels
Get PRO
December '24
+237
in 0 channels
Get PRO
November '24
+1 122
in 0 channels
Get PRO
October '24
+1 120
in 0 channels
Get PRO
September '24
+1 527
in 1 channels
Get PRO
August '24
+1 128
in 1 channels
Get PRO
July '24
+1 216
in 0 channels
Get PRO
June '24
+781
in 1 channels
Get PRO
May '24
+797
in 1 channels
Get PRO
April '24
+808
in 1 channels
Get PRO
March '24
+821
in 2 channels
Get PRO
February '24
+753
in 1 channels
Get PRO
January '24
+768
in 0 channels
Get PRO
December '23
+716
in 1 channels
Get PRO
November '23
+96
in 1 channels
Get PRO
October '23
+86
in 0 channels
Get PRO
September '23
+73
in 0 channels
Get PRO
August '23
+90
in 0 channels
Get PRO
July '23
+107
in 0 channels
Get PRO
June '23
+105
in 0 channels
Get PRO
May '23
+169
in 0 channels
Get PRO
April '23
+128
in 0 channels
Get PRO
March '23
+84
in 0 channels
Get PRO
February '23
+75
in 0 channels
Get PRO
January '23
+71
in 0 channels
Get PRO
December '22
+74
in 0 channels
Get PRO
November '22
+149
in 0 channels
Get PRO
October '22
+90
in 0 channels
Get PRO
September '22
+138
in 0 channels
Get PRO
August '22
+77
in 0 channels
Get PRO
July '22
+50
in 0 channels
Get PRO
June '22
+96
in 0 channels
Get PRO
May '22
+75
in 0 channels
Get PRO
April '22
+80
in 0 channels
Get PRO
March '22
+65
in 0 channels
Get PRO
February '22
+26
in 0 channels
Get PRO
January '22
+56
in 0 channels
Get PRO
December '21
+44
in 0 channels
Get PRO
November '21
+39
in 0 channels
Get PRO
October '21
+61
in 0 channels
Get PRO
September '21
+66
in 0 channels
Get PRO
August '21
+65
in 0 channels
Get PRO
July '21
+96
in 0 channels
Get PRO
June '21
+120
in 0 channels
Get PRO
May '21
+130
in 0 channels
Get PRO
April '21
+812
in 0 channels
| Date | Subscriber Growth | Mentions | Channels | |
| 22 September | +2 | |||
| 21 September | +12 | |||
| 20 September | +10 | |||
| 19 September | +18 | |||
| 18 September | +10 | |||
| 17 September | +16 | |||
| 16 September | +9 | |||
| 15 September | +15 | |||
| 14 September | +4 | |||
| 13 September | +24 | |||
| 12 September | +9 | |||
| 11 September | +9 | |||
| 10 September | +13 | |||
| 09 September | +4 | |||
| 08 September | +11 | |||
| 07 September | +9 | |||
| 06 September | +16 | |||
| 05 September | +11 | |||
| 04 September | +5 | |||
| 03 September | 0 | |||
| 02 September | +15 | |||
| 01 September | +4 |
Channel Posts
Review of Vaccines for Cancer
https://jamanetwork.com/journals/jama/fullarticle/2854262
This translational science review examines antigen-based cancer vaccines, which help patients develop immunity to the cellular protein expressed by cancer by stimulating the adaptive immune system.
| 2 | Protecting Patients From Politicization of Federal Science
https://jamanetwork.com/journals/jama/fullarticle/2854263
This Perspective discusses new proposed federal rules regarding research funding; the ways these rules could affect patients, communities, and taxpayers; and how federally supported research has benefitted public health. | 235 |
| 3 | Medicare Advantage Enrollment and Access to Kidney Transplant After the 21st Century Cures Act
https://jamanetwork.com/journals/jama/fullarticle/2854264
This cohort study characterizes differences in transplant access between Medicare Advantage and traditional Medicare beneficiaries with end-stage kidney disease (ESKD) during the first 3 years after the 21st Century Cures Act (2021-2023), a period of rapid Medicare Advantage enrollment growth. | 220 |
| 4 | Hearing Aids for Mild to Moderate Hearing Loss in Adults—Reply
https://jamanetwork.com/journals/jama/fullarticle/2854265
In Reply In a letter about our recent Insights article on hearing aids for adults with mild to moderate hearing loss, Dr Kim raises an important point regarding the role of professional involvement, and specifically informational counseling in patients with hearing loss and comorbid chronic tinnitus who pursue OTC amplification. | 184 |
| 5 | Hearing Aids for Mild to Moderate Hearing Loss in Adults
https://jamanetwork.com/journals/jama/fullarticle/2854266
To the Editor A recent JAMA Insights article provided a timely discussion on the role of over-the-counter (OTC) hearing aids. It had been previously demonstrated that self-fit OTC devices can achieve outcomes comparable to audiologist-fit hearing aids, which is particularly relevant in the current context of changing approaches to hearing aid provision. It is encouraging to see this issue addressed in a high-impact journal, increasing awareness among clinicians and the public. | 173 |
| 6 | Buprenorphine via Telehealth
https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/2854074
This Viewpoint calls for further research to guide clinicians and policymakers in increasing access and effective use of telehealth prescribing of buprenorphine for pregnant and postpartum women. | 161 |
| 7 | Steatotic Liver Disease Risk Scores to Predict Cirrhosis and Hepatocellular Carcinoma
https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/2854075
This cohort study assesses the clinical utility of steatotic liver disease risk scores for predicting cirrhosis and hepatocellular carcinoma in patients with noncirrhotic steatotic liver disease. | 156 |
| 8 | Antidiscrimination Laws and Kidney Transplant for Patients With Developmental Disabilities
https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/2854076
This cohort study explores the association between transplant antidiscrimination state laws and rates of transplant evaluation and receipt among patients with end-stage kidney disease with or without intellectual and/or developmental disabilities. | 153 |
| 9 | Risk Stratification in Steatotic Liver Disease
https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/2854077
With the rise in steatotic liver disease (SLD) and the limited capacity of hepatology specialists, primary care is under growing pressure to identify high-risk patients and establish clear referral pathways to hepatology. The American Association for the Study of Liver Disease (AASLD) 2023 national guidelines recommend the Fibrosis-4 (FIB-4) Index as the primary noninvasive test (NIT) to screen at-risk adults for advanced fibrosis before confirmatory testing and referral to hepatology. Ongoing advances in SLD-related NITs provide an opportunity for primary care to consider improved screening pathways. | 142 |
| 10 | When to Use the HINTS Examination in Patients With Dizziness
https://jamanetwork.com/journals/jamaneurology/fullarticle/2854363
This narrative review discusses when it is appropriate to use the Head Impulse, Nystagmus, Test of Skew (HINTS) examination to assess patients with dizziness. | 173 |
| 11 | A Harmonized Visual Reading Framework for Tau PET Staging in Alzheimer Disease
https://jamanetwork.com/journals/jamaneurology/fullarticle/2854364
This cross-sectional study develops and validates a harmonized tau positron emission tomography (PET) visual reading framework across radiotracers that stages tau burden into 5 classes. | 175 |
| 12 | Portable Low-Field MRI of the Brain in Clinic and Community Settings
https://jamanetwork.com/journals/jamaneurology/fullarticle/2854365
This cohort study evaluates portable, low-field magnetic resonance imaging (MRI) against conventional MRI in memory clinic and community cohorts. | 174 |
| 13 | Unprecedented In Vivo MRI Resolution of Basal Ganglia at 11.7 T
https://jamanetwork.com/journals/jamaneurology/fullarticle/2854366
This case report describes 11.7-T in vivo human brain magnetic resonance imaging (MRI) of the basal ganglia in 2 healthy volunteers. | 194 |
| 14 | Error in Funding/Support
https://jamanetwork.com/journals/jamaneurology/fullarticle/2854367
In the Original Investigation titled “Automated Speech Analysis to Identify Clinical, Anatomical, and Pathological Variants of Primary Progressive Aphasia,” published on August 3, 2026, there was an error in the Funding/Support section. This section should have read, “This work was supported by National Institutes of Health (NIH) grants R00AG066934 and RF1AG091509 (Dr Vonk), R01NS050915, K24DC015544, and R01AG075775 (Dr Gorno-Tempini), P01AG019724 (Drs Gorno-Tempini, Rosen, and Seeley), and U19AG063911 (Dr Rosen) and by NIH/National Institute on Deafness and Other Communication Disorders grant R01DC016291 (Dr Henry). This work was also supported by a 2025 UCSF Catalyst Award for the Development of Diagnostics, Devices, Therapeutics and Digital/Computational Health (Dr Vonk), cofunded by the UCSF Weill Institute for Neurosciences.” This article was corrected online. | 225 |
| 15 | FDA Approves 2 New Alzheimer Disease Blood Tests
https://jamanetwork.com/journals/jama/fullarticle/2854427
The US Food and Drug Administration (FDA) approved 2 new blood tests to detect Alzheimer disease in adults with cognitive symptoms, including 1 for those as young as 40 years old. | 719 |
| 16 | Mpox Virus Transitions Toward Endemicity
https://jamanetwork.com/journals/jama/fullarticle/2854428
Surveillance data from the US Centers for Disease Control and Prevention (CDC) suggest that the clade IIb mpox virus is transitioning toward endemic circulation. | 694 |
| 17 | FDA Approves New Treatment for Advanced Pancreatic Cancer
https://jamanetwork.com/journals/jama/fullarticle/2854429
The US Food and Drug Administration (FDA) approved a first-in-class therapy for patients with metastatic pancreatic cancer. | 662 |
| 18 | JAMA Editors' Summary Podcast September 18, 2026
https://jamanetwork.com/journals/jama/fullarticle/2854455
Listen to the JAMA Editor’s Summary for an overview and discussion of the important articles appearing in JAMA. | 623 |
| 19 | Management Consultant Use by Nonprofit Hospitals
https://jamanetwork.com/journals/jama/fullarticle/2854259
To the Editor Dr Bruch and colleagues provided an important analysis of management consulting use in nonprofit hospitals, but a critical methodological limitation warrants consideration before their null finding is interpreted as evidence that consultants add no value. | 723 |
| 20 | The Dangers of Perverted Appetite
https://jamanetwork.com/journals/jama/fullarticle/2854261
Abnormalities of appetite involve a considerable variety of peculiarities in food intake. Aversion to food may range in intensity from the ordinary anorexia, or loss of appetite, that is familiar to physicians, to an extreme loathing for food. A recent writer has remarked that bulimia, or increase of appetite, is certainly not abnormal so long as it is a simple demand for increased food, as in convalescence; although it might be described as perverted at the court of the emperor Nero, where decadent diners retired for emesis between courses. The “craving sensation” common in catarrhal gastritis and temporarily relieved by eating, and the similar sensation observed in worm infections in children, we are further reminded, are commonly attributed to irritation of the intestinal tract, without further attempt to relate clinically observed effect with physiologic cause. | 674 |
